Literature DB >> 12112649

DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor.

Jill Glasspool-Malone1, Peter R Steenland, Ruth J McDonald, Rigoberto A Sanchez, Tammara L Watts, Joseph Zabner, Robert W Malone.   

Abstract

BACKGROUND: Nuclease activity present within respiratory tissues contributes to the rapid clearance of injected DNA and therefore may reduce the transfection activity of directly injected transgenes. Most gene transfer technologies transduce or transfect murine tissues more efficiently than corresponding primate tissues. Therefore, it is prudent to assess the utility of novel gene transfer strategies in both rodent and primate models before proceeding with further development.
METHODS: This study analyzed the effects of ATA (a nuclease inhibitor) on the direct transfection of macaque and murine lung tissue; compared the levels of DNase activity in murine, primate, and human lung fluids; and tested the inhibitory activity of ATA on the DNase activity present in these samples. Fluorescent microspheres were used to detect areas of transfection in lung.
RESULTS: Intratracheal administration of a nuclease inhibitor (ATA) with naked DNA (0.5 microg ATA/g body weight) enhanced direct transfection efficacy in macaque lung by over 86-fold and by over 54-fold in mouse lung. Hematoxylin and eosin staining showed no apparent tissue toxicity. Moreover, macaque, human, and mouse lung fluids were found to possess similar levels of DNase activity and this activity was inhibited by similar concentrations of ATA. The authors also successfully pioneered the use of carboxylate-modified microsphere tracers to identify areas of transfection and/or treatment.
CONCLUSION: This work provides evidence that using direct nuclease inhibitors will enhance lung transfection and that nuclease activity is present in all lung fluids tested, which can be inhibited by the use of direct DNase inhibitors. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112649     DOI: 10.1002/jgm.259

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  Gene transfer: how can the biological barriers be overcome?

Authors:  Jean-Michel Escoffre; Justin Teissié; Marie-Pierre Rols
Journal:  J Membr Biol       Date:  2010-07-10       Impact factor: 1.843

Review 2.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

3.  Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

Authors:  Jørgen de Jonge; Johanna M Leenhouts; Marijke Holtrop; Pieter Schoen; Peter Scherrer; Pieter R Cullis; Jan Wilschut; Anke Huckriede
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

4.  Time-course determination of plasmid content in eukaryotic and prokaryotic cells using real-time PCR.

Authors:  Elisabete Carapuça; Adriano R Azzoni; Duarte M F Prazeres; Gabriel A Monteiro; Filipe J M Mergulhão
Journal:  Mol Biotechnol       Date:  2007-10       Impact factor: 2.695

5.  DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.

Authors:  Dorian McIlroy; Benoît Barteau; Jeannette Cany; Peggy Richard; Clothilde Gourden; Sophie Conchon; Bruno Pitard
Journal:  Mol Ther       Date:  2009-05-05       Impact factor: 11.454

6.  Uptake of foreign nucleic acids in kidney tubular epithelial cells deficient in proapoptotic endonucleases.

Authors:  Timea Buzder; Xiaoyan Yin; Xiaoying Wang; Gaspar Banfalvi; Alexei G Basnakian
Journal:  DNA Cell Biol       Date:  2009-09       Impact factor: 3.311

7.  SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.

Authors:  V V Oberemok; K V Laikova; K A Yurchenko; N A Marochkin; I I Fomochkina; A V Kubyshkin
Journal:  Inflamm Res       Date:  2020-07-12       Impact factor: 6.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.